Surescreen Diagnostics

Rapid, reliable screening solutions

SureScreen Diagnostics is a UK-based leader in diagnostic innovation, delivering rapid, accurate, and cost-effective testing solutions for healthcare providers, laboratories, and occupational health services.

With over 25 years of experience, we empower organisations to make informed decisions faster through advanced diagnostic technology and responsive support.

What we offer:

- Rapid point-of-care testing - our CE-marked lateral flow tests provide reliable results within minutes—supporting faster diagnosis and improved patient outcomes.

- Mobile-first point of care testing with ClearScreen - capture, interpret & store results in patient records with a mobile phone based app.

- Occupational health services - from Health Surveillance to Drug & Alcohol Screening, our services are trusted by leading employers across the UK.

- Custom R&D services - We offer bespoke R&D support to develop and manufacture lateral flow devices tailored to specific clinical needs. Clients benefit from in-house expertise, ISO 13485:2016 compliance, and rapid prototyping.

Why choose SureScreen Diagnostics?

- British manufacturing: quality-assured production with full regulatory compliance

- Rapid turnaround: fast, scalable delivery across the UK and international markets

- Sustainability commitment: we actively reduce environmental impact through carbon reduction initiatives.

- Trusted partner: our solutions are used by NHS Trusts, private clinics, employers, and global distributors.

Key products:

- Covid-19 & Flu A/B Antigen Combined Rapid Test Cassette - Pioneering combination rapid lateral flow test to detect both COVID-19 and Influenza A&B from one swab sample. It is the first dual test in the UK to be awarded CTDA approval.

- Strep A Antigen Rapid Test Cassette - Strep A rapid lateral flow test selectively detects Group A Streptococcus antigen in a throat swab specimen.

- RSV Antigen Rapid Test Cassette - RSV Antigen rapid lateral flow test selectively detects of Respiratory Syncytial Virus antigens (viral fusion protein) in nasal swab, throat swab or nasopharyngeal swab.

- SureScreen Digital Powered by TestCard - A new digital clinical tool that accurately reads, records, and reports lateral flow devices This digital solution optimises the processes of recording and reporting of lateral flow tests to support better patient outcomes.

Whether you're looking for off-the-shelf tests, contract development, or national screening support, we're here to help.